NASDAQ:CGON | Cash Flow Statement | CG Oncology, Inc.

Complete source-backed cash-flow history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$79.06M
2026-03-31-$60.2M$841,000.00-$56.94M$304,000.00-$334.85M$393M
2025-12-31-$41.31M$849,000.00-$36.22M$7,000.00-$75.51M$99.07M
2025-09-30-$43.81M
2025-06-30-$41.43M
2025-03-31-$34.45M$24,000.00-$29.28M$16,000.00-$186.77M$450,000.00
2024-12-31-$31.8M$0.00-$20.66M$209,000.00$10.91M$223.41M
2024-09-30-$20.41M
2024-06-30-$18.9M
2024-03-31-$16.93M$4,000.00-$26.01M$12,000.00-$307.44M$402.66M
2023-12-31-$16.56M$4,000.00-$14.65M$15.53M-$2.9M
2023-09-30-$11.77M
2023-06-30-$11.61M
2023-03-31-$8.67M$4,000.00-$7.99M-$78.7M-$765,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$161M$1.45M-$132.35M$134,000.00-$245.82M$153.59M
2024-12-31-$88.04M$32,000.00-$78.71M$234,000.00-$300.76M$628.28M
2023-12-31-$48.61M$17,000.00-$45.68M-$121.2M$87M